MedTrace Logo

Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System

NCT07509775 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2026-04-09

No results posted yet for this study

Summary

This study is a multicentre, ambidirectional, observational cohort study. The ambidirectional design incorporates both the collection of retrospective data from the three years prior to enrolment, and a prospective follow-up period of up to two years. The study is designed to evaluate the long-term effects of Integrated Medicine on radiographic progression in patients diagnosed with Ankylosing spondylitis (AS).

Conditions

  • Ankylosing Spondylitis (AS)

Sponsors & Collaborators

  • Henan Province Hospital of Traditional Chinese Medicine (the Second Affiliated Hospital of Henan University of Chinese Medicine)

    collaborator UNKNOWN

  • Guangxi Ruikang Hospital

    collaborator OTHER

  • The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine

    collaborator OTHER

  • Beijing Electric Power Hospital

    collaborator OTHER

  • Hunan University of Traditional Chinese Medicine

    collaborator OTHER

  • Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

    collaborator OTHER

  • Xi'an Fifth Hospital

    collaborator UNKNOWN

  • Affiliated Hospital of Shandong University of Traditional Chinese Medicine

    collaborator OTHER

  • Shanghai University of Traditional Chinese Medicine

    collaborator OTHER

  • Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital

    collaborator UNKNOWN

  • China-Japan Friendship Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-19
Primary Completion
2027-12-31
Completion
2028-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07509775 on ClinicalTrials.gov